Keywords: critical, therapeutics, submits, snda, fda, submitted, supplemental

Critical Therapeutics submits sNDA to US FDA

Article | 11 April 2005

Print This

Critical Therapeutics has submitted a supplemental New Drug Application to the US Food and Drug Administration for its investigational asthma ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in